Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD
Clinical trial NCT02161575 · COMPLETED
Trial details
- NCT number
- NCT02161575
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-28
- Primary completion
- 2017-09-14
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.